Gland Pharma Ltd. — documents
110 files on disk. SHA-256 from the acquisition manifests; links open the exchange copy.
| Class | Period | Scope / kind | Filing date | File | SHA-256 |
|---|---|---|---|---|---|
| Results XBRL (NSE) | 2020-12-31 | Standalone | — | INDAS_66233_397574_22012021061049_WEB.xm | 15bc2e0dc29dfac5 |
| Results XBRL (NSE) | 2021-03-31 | Consolidated | — | INDAS_70061_448542_18052021042553_WEB.xm | b02b6ea64a440f45 |
| Results XBRL (NSE) | 2021-03-31 | Standalone | — | INDAS_70063_448547_18052021082200_WEB.xm | b9a2010ccfb3662c |
| Results XBRL (NSE) | 2021-06-30 | Consolidated | — | INDAS_73191_494110_21072021100520_WEB.xm | 4057e56ddf61353c |
| Results XBRL (NSE) | 2021-06-30 | Standalone | — | INDAS_73193_494127_21072021103521_WEB.xm | cda30233547adfc6 |
| Results XBRL (NSE) | 2021-09-30 | Consolidated | — | INDAS_76621_544931_22102021054112_WEB.xm | e732ac72fbe221b2 |
| Results XBRL (NSE) | 2021-09-30 | Standalone | — | INDAS_76639_545056_22102021072704_WEB.xm | aec88e4baee9962e |
| Results XBRL (NSE) | 2021-12-31 | Consolidated | — | INDAS_80290_597004_21012022041647_WEB.xm | cbfd24b61426b950 |
| Results XBRL (NSE) | 2021-12-31 | Standalone | — | INDAS_80297_597090_21012022044947_WEB.xm | 4480b2342c25254e |
| Results XBRL (NSE) | 2022-03-31 | Standalone | — | INDAS_84868_657325_20052022031003_WEB.xm | 08dbb64411bdbdf6 |
| Results XBRL (NSE) | 2022-03-31 | Consolidated | — | INDAS_84872_657346_20052022031748_WEB.xm | 6ed4d157424f4c43 |
| Results XBRL (NSE) | 2022-09-30 | Standalone | — | INDAS_795705_6448_26102022163653_WEB.xml | 8cf41982877c28e6 |
| Results XBRL (NSE) | 2022-09-30 | Consolidated | — | INDAS_795706_6448_26102022163653_WEB.xml | c11bdb95dc2912fb |
| Results XBRL (NSE) | 2022-12-31 | Standalone | — | INDAS_87671_777675_23012023054648_WEB.xm | d1ecaeba8aecb314 |
| Results XBRL (NSE) | 2022-12-31 | Consolidated | — | INDAS_87672_777678_23012023054941_WEB.xm | bb9b24b959259940 |
| Results XBRL (NSE) | 2023-03-31 | Standalone | — | INDAS_92078_846656_19052023030033.xml | 8675c953ce79e20c |
| Results XBRL (NSE) | 2023-03-31 | Consolidated | — | INDAS_92080_846662_19052023030202.xml | 9c80a35af635469a |
| Results XBRL (NSE) | 2023-06-30 | Consolidated | — | INDAS_95597_910434_07082023080434.xml | fa4a1df41f90cee7 |
| Results XBRL (NSE) | 2023-06-30 | Standalone | — | INDAS_95598_910440_07082023080613.xml | 415413db7897e00b |
| Results XBRL (NSE) | 2023-09-30 | Consolidated | — | INDAS_99019_978134_06112023082108.xml | 4c64f2c9247805cf |
| Results XBRL (NSE) | 2023-09-30 | Standalone | — | INDAS_99021_978141_06112023082240.xml | 6eba62988347a7ec |
| Results XBRL (NSE) | 2023-12-31 | Standalone | — | INDAS_104164_1055416_14022024053135.xml | a2eeab34e2cd1282 |
| Results XBRL (NSE) | 2023-12-31 | Consolidated | — | INDAS_104168_1055428_14022024053311.xml | 31f73de1cf436f1b |
| Results XBRL (NSE) | 2024-03-31 | Standalone | — | INDAS_106744_1134473_22052024081751.xml | 6697d3b0416e5cf0 |
| Results XBRL (NSE) | 2024-03-31 | Consolidated | — | INDAS_106746_1134480_22052024081906.xml | 4c5657b9f98c0936 |
| Results XBRL (NSE) | 2024-06-30 | Standalone | — | INDAS_110504_1214173_06082024053738.xml | 8a6d47c72199b096 |
| Results XBRL (NSE) | 2024-06-30 | Consolidated | — | INDAS_110505_1214178_06082024053848.xml | a0b43291ad398818 |
| Results XBRL (NSE) | 2024-09-30 | Standalone | — | INDAS_114110_1296432_04112024061759.xml | eb52ac0b4a85f748 |
| Results XBRL (NSE) | 2024-09-30 | Consolidated | — | INDAS_114111_1296440_04112024061913.xml | c9bea819673cca52 |
| Results XBRL (NSE) | 2024-12-31 | Standalone | — | INDAS_118525_1369687_03022025094436.xml | cdd7157c367f3ac6 |
| Results XBRL (NSE) | 2024-12-31 | Consolidated | — | INDAS_118526_1369690_03022025094552.xml | d05d65d80f6a63f0 |
| Results XBRL (NSE) | 2025-03-31 | Standalone | — | INTEGRATED_FILING_INDAS_1445031_20052025 | 024d04e8afdb2593 |
| Results XBRL (NSE) | 2025-03-31 | Consolidated | — | INTEGRATED_FILING_INDAS_1445037_20052025 | 9bae6bced84d032d |
| Results XBRL (NSE) | 2025-06-30 | Standalone | — | INTEGRATED_FILING_INDAS_1503016_05082025 | fba89d13e92a785e |
| Results XBRL (NSE) | 2025-06-30 | Consolidated | — | INTEGRATED_FILING_INDAS_1503022_05082025 | 245f8f1c36f1e534 |
| Results XBRL (NSE) | 2025-09-30 | Standalone | — | INTEGRATED_FILING_INDAS_1564246_03112025 | 258f0d700c4dab1b |
| Results XBRL (NSE) | 2025-09-30 | Consolidated | — | INTEGRATED_FILING_INDAS_1564247_03112025 | 6a26b79f3d5bb112 |
| Results XBRL (NSE) | 2025-12-31 | Standalone | — | INTEGRATED_FILING_INDAS_1613348_29012026 | e4ce818bc0ad655e |
| Results XBRL (NSE) | 2025-12-31 | Consolidated | — | INTEGRATED_FILING_INDAS_1613349_29012026 | 93ae5d097e5679bd |
| Results XBRL (NSE) | 2026-03-31 | Standalone | — | INTEGRATED_FILING_INDAS_1668085_15052026 | 85e3c54267d8a656 |
| Results XBRL (NSE) | 2026-03-31 | Consolidated | — | INTEGRATED_FILING_INDAS_1668086_15052026 | 3bb78360a3ce7163 |
| Results XBRL (NSE) | 2026-06-30 | Standalone | — | INTEGRATED_FILING_INDAS_1711082_10082026 | 0f02681201fed8fb |
| Results XBRL (NSE) | 2026-06-30 | Consolidated | — | INTEGRATED_FILING_INDAS_1711083_10082026 | 64e0c95b3545b3d0 |
| Results XBRL (BSE) | 2020-12-31 | Standalone | 2021-01-22T17:55:12 | Main_Ind_As_543245_2212021173326.xml | 59274a9119db5ba3 |
| Results XBRL (BSE) | 2021-03-31 | Consolidated | 2021-05-18T10:00:41 | Main_Ind_As_543245_175202119251.xml | a446dd9abce33234 |
| Results XBRL (BSE) | 2021-03-31 | Standalone | 2021-05-18T10:00:41 | Main_Ind_As_543245_1752021193433.xml | 8e737553f010b623 |
| Results XBRL (BSE) | 2021-06-30 | Consolidated | 2021-07-22T13:02:41 | Main_Ind_As_543245_217202117527.xml | 8d3866746febf0ed |
| Results XBRL (BSE) | 2021-06-30 | Standalone | 2021-07-22T13:02:41 | Main_Ind_As_543245_217202117626.xml | 20f9d85fc82d3e9f |
| Results XBRL (BSE) | 2021-09-30 | Consolidated | 2021-10-23T14:04:48 | Main_Ind_As_543245_2210202116143.xml | f2069b573e4bab42 |
| Results XBRL (BSE) | 2021-09-30 | Standalone | 2021-10-23T14:04:48 | Main_Ind_As_543245_221020211638.xml | a81a5aa9d723cf62 |
| Results XBRL (BSE) | 2021-12-31 | Consolidated | 2022-01-21T16:40:54 | Main_Ind_As_543245_2112022163920.xml | 68d24b8780706354 |
| Results XBRL (BSE) | 2021-12-31 | Standalone | 2022-01-21T16:40:54 | Main_Ind_As_543245_2112022164026.xml | 77e5d42e8a815727 |
| Results XBRL (BSE) | 2022-03-31 | Consolidated | 2022-05-20T15:45:21 | Main_Ind_As_543245_205202215197.xml | 7fb5f51227c8533e |
| Results XBRL (BSE) | 2022-03-31 | Standalone | 2022-05-20T15:45:21 | Main_Ind_As_543245_205202215543.xml | 017e057855e81329 |
| Results XBRL (BSE) | 2022-06-30 | Consolidated | 2022-07-20T16:57:29 | Main_Ind_As_543245_2072022162530.xml | 22a48b892970cdf3 |
| Results XBRL (BSE) | 2022-06-30 | Standalone | 2022-07-20T16:57:29 | Main_Ind_As_543245_2072022162619.xml | b89f8e50372dff00 |
| Results XBRL (BSE) | 2022-09-30 | Consolidated | 2022-10-27T10:08:32 | Main_Ind_As_543245_2610202216315.xml | c11bdb95dc2912fb |
| Results XBRL (BSE) | 2022-09-30 | Standalone | 2022-10-27T10:08:32 | Main_Ind_As_543245_2610202216337.xml | 8cf41982877c28e6 |
| Annual report | 2021-03-31 | grade A | 2021-08-02T00:00:00 | 69213543245.pdf | 950913d49137bdd3 |
| Annual report | 2022-03-31 | grade A | 2022-08-05T00:00:00 | 74100543245.pdf | d35a573bb4b96bae |
| Annual report | 2023-03-31 | grade A | 2023-08-08T22:13:29.153 | b84f37da-ded1-4d8c-8c05-6102956ff833.pdf | ecf360c6179cca94 |
| Annual report | 2024-03-31 | grade A | 2024-08-07T19:10:53.103 | 6ea4005e-beba-4a51-b5e2-bd205e23c8a4.pdf | 09de7622050aae88 |
| Annual report | 2025-03-31 | grade A | 2025-07-31T13:18:53.06 | e2c13564-f778-4289-b41d-f77fa88c1c3b.pdf | c85d30f46cec4efc |
| Annual report | 2026-03-31 | grade A | 2026-07-31T20:21:04.97 | fc85ba48-93f1-450b-9336-f0490e6172fa.pdf | 6949d684f766579e |
| Concall | 2020-12-31 | TRANSCRIPT | — | Date_20210210_Gland Pharma Ltd._Concal_Q3FY21.pdf | 8e08fb25d78ed49a |
| Concall | 2021-03-31 | TRANSCRIPT | — | Date_20210521_Gland Pharma Ltd._Concal_Q4FY21.pdf | 125990511617a36f |
| Concall | 2021-06-30 | TRANSCRIPT | — | Date_20210731_Gland Pharma Ltd._Concal_Q1FY22.pdf | 2ef354e61648dc6a |
| Concall | 2021-09-30 | TRANSCRIPT | — | Date_20211103_Gland Pharma Ltd._Concal_Q2FY22.pdf | f76816bd744bac0d |
| Concall | 2021-12-31 | TRANSCRIPT | — | Date_20220128_Gland Pharma Ltd._Concal_Q3FY22.pdf | 7eb80732ccc37020 |
| Concall | 2022-03-31 | TRANSCRIPT | — | Date_20220526_Gland Pharma Ltd._Concal_Q4FY22.pdf | 6a8c7315fe6258ab |
| Concall | 2022-06-30 | TRANSCRIPT | — | Date_20220727_Gland Pharma Ltd._Concal_Q1FY23.pdf | 85df9637c570662c |
| Concall | 2022-09-30 | TRANSCRIPT | — | Date_20221102_Gland Pharma Ltd._Concal_Q2FY23.pdf | 5bf664dc5a235e38 |
| Concall | 2022-12-31 | TRANSCRIPT | — | Date_20230131_Gland Pharma Ltd._Concal_Q3FY23.pdf | 825f783f38c9688c |
| Concall | 2023-03-31 | TRANSCRIPT | — | Date_20230525_Gland Pharma Ltd._Concal_Q4FY23.pdf | 285cb6bb0f623ed3 |
| Concall | 2023-06-30 | TRANSCRIPT | — | Date_20230811_Gland Pharma Ltd._Concal_Q1FY24.pdf | dfee5b837f5c6226 |
| Concall | 2023-12-31 | TRANSCRIPT | — | Date_20240221_Gland Pharma Ltd._Concal_Q3FY24.pdf | 8c544b6b9861b624 |
| Concall | 2024-03-31 | TRANSCRIPT | — | Date_20240529_Gland Pharma Ltd._Concal_Q4FY24.pdf | 3fe28bf021372a98 |
| Concall | 2024-06-30 | TRANSCRIPT | — | Date_20240812_Gland Pharma Ltd._Concal_Q1FY25.pdf | 0e67099e90dff235 |
| Concall | 2024-09-30 | TRANSCRIPT | — | Date_20241111_Gland Pharma Ltd._Concal_Q2FY25.pdf | 3a185a3ff93f8d47 |
| Concall | 2024-12-31 | TRANSCRIPT | — | Date_20250210_Gland Pharma Ltd._Concal_Q3FY25.pdf | 84a32828488b23cb |
| Concall | 2025-03-31 | TRANSCRIPT | — | Date_20250527_Gland Pharma Ltd._Concal_Q4FY25.pdf | 6ceffc079564c7fb |
| Concall | 2025-06-30 | TRANSCRIPT | — | Date_20250811_Gland Pharma Ltd._Concal_Q1FY26.pdf | 6a3ddd4c2ec9d46f |
| Concall | 2025-09-30 | TRANSCRIPT | — | Date_20251107_Gland Pharma Ltd._Concal_Q2FY26.pdf | e636f649682fd772 |
| Concall | 2025-12-31 | TRANSCRIPT | — | Date_20260203_Gland Pharma Ltd._Concal_Q3FY26.pdf | a0441cc1bf8480a5 |
| Concall | 2026-03-31 | TRANSCRIPT | — | Date_20260520_Gland Pharma Ltd._Concal_Q4FY26.pdf | bf433eb64bc2ff59 |
| Concall | 2026-06-30 | TRANSCRIPT | — | Date_20260817_Gland Pharma Ltd._Concal_Q1FY27.pdf | aa28585fbb56def6 |
| Shareholding XBRL | 2021-09-30 | — | — | SHP_162107_534819_16102021052315_WEB.xml | eaa5db77ffcf652f |
| Shareholding XBRL | 2021-12-31 | — | — | SHP_164340_585601_13012022105509_WEB.xml | 1846b912a998344a |
| Shareholding XBRL | 2022-03-31 | — | — | SHP_167137_636804_15042022061306_WEB.xml | 0af447867debd351 |
| Shareholding XBRL | 2022-06-30 | — | — | SHP_169374_688599_14072022012125_WEB.xml | f08e4062c2fe1ae5 |
| Shareholding XBRL | 2022-09-30 | — | — | SHP_171554_731023_18102022022006_WEB.xml | dc69398974f8fe2e |
| Shareholding XBRL | 2022-12-31 | — | — | SHP_173882_762715_11012023055539_WEB.xml | 8d5747951990e33c |
| Shareholding XBRL | 2023-03-31 | — | — | SHP_176629_819061_14042023031734_WEB.xml | e0b856f5313269d3 |
| Shareholding XBRL | 2023-06-30 | — | — | SHP_179217_887823_17072023043101_WEB.xml | f8f8d12b065f4e5c |
| Shareholding XBRL | 2023-09-30 | — | — | SHP_182066_957277_18102023123819_WEB.xml | 26098f45cd6b9f42 |
| Shareholding XBRL | 2023-12-31 | — | — | SHP_183992_1018470_12012024034147_WEB.xm | 6ccb2f76c6e24057 |
| Shareholding XBRL | 2024-03-31 | — | — | SHP_186687_1091571_15042024123024_WEB.xm | dab392083be88df9 |
| Shareholding XBRL | 2024-06-30 | — | — | SHP_189467_1217052_08082024050847_WEB.xm | f1196a09c3df6fe2 |
| Shareholding XBRL | 2024-09-30 | — | — | SHP_192585_1313675_15112024093903_WEB.xm | df36a88d1f9cc84a |
| Shareholding XBRL | 2024-12-31 | — | — | SHP_195649_1353283_20012025055532_WEB.xm | 421c160c9819f744 |
| Shareholding XBRL | 2025-03-31 | — | — | SHP_197272_1415324_16042025102335_WEB.xm | 72398a9ce917f90c |
| Shareholding XBRL | 2025-06-30 | — | — | SHP_1486447_18072025031218_WEB.xml | 7e4d10752edab510 |
| Shareholding XBRL | 2025-09-30 | — | — | SHP_1548526_15102025124130_WEB.xml | 3217cf91673f9df7 |
| Shareholding XBRL | 2025-12-31 | — | — | SHP_1602551_16012026052655_WEB.xml | 5d75e07478dd2a2d |
| Shareholding XBRL | 2026-03-31 | — | — | SHP_1653191_17042026041011_WEB.xml | 71e4bc411e820fbe |
| Shareholding XBRL | 2026-06-30 | — | — | SHP_1697195_20072026055314_WEB.xml | 4bf5a51f6aba23ea |
| Related-party XBRL | 2023-03-31 | — | — | RPT_846214_18052023095140_WEB.xml | 74db32474b750182 |
| Related-party XBRL | 2023-09-30 | — | — | RPT_978128_06112023081745_WEB.xml | ff03d113530d5536 |
| Related-party XBRL | 2024-03-31 | — | — | RPT_1134442_22052024080102_WEB.xml | c1af6d59746db536 |
| Related-party XBRL | 2024-09-30 | — | — | RPT_1296466_04112024062851_WEB.xml | e5223f263dec1931 |